-
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Period Activity
Post on 2/11/21
-
Philips Named Top Place to Work on Forbes’ “America’s Best Employers of 2021” List
Post on 2/11/21
-
BIONIK Laboratories Reports Fiscal 2021 Q3 Financial Results
Post on 2/11/21
-
CyberArk Announces Record Fourth Quarter and Full Year 2020 Results
Post on 2/11/21
-
AlloVir Reports Full Year 2020 Financial Results
Post on 2/11/21
-
Dr. Robert Cardales-Stearns, DMD Joins Natick Family Dental
Post on 2/11/21
-
Genocea Provides Fourth Quarter 2020 Corporate Update
Post on 2/11/21
-
Eagle Bulk Shipping Acquires Three Supramaxes
Post on 2/11/21
-
SeaChange International Appoints Matthew Stecker to Board of Directors
Post on 2/11/21
-
CSP Reports Fiscal First Quarter 2021 Results
Post on 2/11/21
-
Peloton Equity Closes $152.25 Million Fund II
Post on 2/11/21
-
Newmark Promotes Mike Frisoli and J.R. McDonald to Vice Chairmen
Post on 2/11/21
-
States That Had the Quickest Weekly Unemployment Claims Recovery – Updated WalletHub Study
Post on 2/11/21
-
Surface Oncology to Appoint Robert Ross, M.D., as CEO
Post on 2/11/21
-
Acorda Therapeutics Sale of Manufacturing Operations to Catalent
Post on 2/11/21
-
Nobl9 Raises $21M in Series B
Post on 2/11/21
-
Is Moderna Stock Overvalued?
Post on 2/11/21
-
The Warren Buffett News You Won't Want to Miss Is 5 Days Away
Post on 2/11/21
-
Can KalVista Pharmaceuticals Stock Fly Higher?
Post on 2/11/21
-
Bioasis Announces Shares for Debt Transaction
Post on 2/10/21
-
Rhythm Pharmaceuticals Closes $172.5M Public Offering
Post on 2/10/21
-
Sensei Biotherapeutics Closes IPO
Post on 2/10/21
-
UKG Ranked #2 on Forbes America’s Best Large Employers 2021 List
Post on 2/10/21
-
KalVista Pharmaceuticals Prices Upsized $193.5M Public Offering of Common Stock
Post on 2/10/21
-
Steve Boutin to Serve as CEO of Sensible Medical
Post on 2/10/21
Boston
